Recently Featured

SGS Receives Regulatory Approval to Restart Human ¹⁴C ADME Trials

February 24, 2026
SGS recently announced it has received formal approval from the Belgian Federal Agency for Nuclear Control (FANC) to resume human ADME (Adsorption, Distribution, Metabolism and Excretion) studies using ¹⁴C-radiolabeled investigational products. The approval enables SGS to reintroduce ¹⁴C human ADME studies at its clinical pharmacology unit in Antwerp, reinstating a highly specialized capability within its…

Recruitment procedure opens for next Executive Director of the European Medicines Agency

February 24, 2026
The vacancy notice for the next Executive Director of the European Medicines Agency (EMA) has been published in the Official Journal of the European Union, marking the commencement of a critical recruitment process. This leadership position is pivotal for overseeing the regulatory framework that governs the approval and monitoring of medicines within the EU, especially…

Regulating Medical Devices in the UK: Key Insights for Pharma Professionals

February 23, 2026
The UK has implemented a comprehensive regulatory framework for medical devices, which is crucial for companies aiming to place their products in Great Britain, Northern Ireland, and the European Union (EU) markets. This framework outlines specific requirements that manufacturers must adhere to, including compliance with safety and performance standards, as well as the necessity for…

ACIP Meeting Postponed, Reasons Remain Unclear

February 23, 2026
The Advisory Committee on Immunization Practices (ACIP) has announced the postponement of its upcoming meeting, a decision that has raised eyebrows within the pharmaceutical and healthcare communities. The committee, which plays a critical role in shaping vaccination policies in the United States, did not provide specific reasons for this delay, leaving industry stakeholders seeking clarity…

Ongoing Cases